News, Resources, & Updates

All
  • All
  • Articles
  • Calendar
  • Compliance
  • Newsletter
  • Position Statements
  • Press Release
  • Regulatory
  • Uncategorized

AAHP Speaking Tour

By Mark Land, AAHP President April 24, 2018 Since the beginning of the year I have embarked on a tour to inform the community of...

Legislative Update: Actions Since FDA’s Draft Guidance

By Pete Evich, AAHP government relations March 1, 2018 Given AAHP’s concerns with the omissions of key homeopathic references and definitions in the United States...
2018 board of directors

2018 Board of Directors Action Plan

By AAHP Board of Directors March 1, 2018 AAHP's Board of Directors is pleased to share the association's 2018 action plan. Focusing on the themes...
aconite

Aconite: A Clinical Snapshot

By Todd Hoover, MD March 1, 2018 Aconitum napellus or Aconite is a commonly used homeopathic medicine for acute conditions. Also traditionally used as a...
Presidents outlook 2018

President’s Outlook 2018

By Mark Land, AAHP President March 1, 2018 Our association concluded one of its most successful years in 2017. The momentum created last year is...

The German Homeopathic Pharmacopeia

By Eric Foxman, AAHP secretary February 1, 2018 A quick look at its history, purpose and contents, as well as the potential for adulteration and...

United States Food and Drug Administration – Good Guidance Practices

By Mark Land, AAHP president February 1, 2018 The Food and Drug Administration (FDA) amended its administrative regulations to codify its policies and procedures for...

Prominence in Advertising and Labeling

By Mark Land, AAHP president February 1, 2018 A search under the term “prominence” yields 43 citations within Title 21 of the U.S. Code of...

Testing the New AAHP Disclaimer for Effectiveness

By Jeremy Kees, PhD, Professor, Marketing & Business Law and Faculty Director, Villanova University February 1, 2018 The American Association of Homeopathic Pharmacists (AAHP) enlisted...